CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- 4 Open-market buy Director bought 10,000 shares at $20.00 ($200,000)
- 4 Open-market buy Director bought 250,000 shares at $20.00 ($5,000,000)
- 4 Open-market buy Director bought 5,000 shares at $20.00 ($100,000)
- 4 Open-market buy Executive Chairperson bought 25,000 shares at $20.00 ($500,000)
- 4 Open-market buy Vice President, Finance bought 17,500 shares at $20.00 ($350,000)
- 4 Open-market buy Director bought 700,000 shares at $20.00 ($14,000,000)
- 4 Open-market buy Former 10% Owner bought 750,000 shares at $20.00 ($15,000,000)
- 3/A Insider 3/A
- 8-K Event Bylaws or fiscal year change · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 12 of 14 · 268 filings